Jenoptik stock: Orders surge as margin reaches 22.2%
Published on 11/10/2026 at 11:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSStrong Orders Lift Jenoptik Outlook
- Revenue reached 803.8 million euros in the first nine months, with semiconductor-related sales up 16.7%.
- Order intake climbed 41.4% to 1,099.2 million euros and lifted the order backlog to 903.2 million euros.
- Management kept its 2026 revenue-growth forecast at 5% to 9% and raised the expected EBITDA margin to around 22%.
Jenoptik reported strong operating progress for the first nine months of 2026 on Tuesday, November 10. The photonics group increased revenue, expanded profitability and lifted order intake sharply, while management confirmed its sales outlook and raised the expected full-year EBITDA margin.
According to the Jenoptik release, revenue rose 6.7% year over year to 803.8 million euros. Growth accelerated in the third quarter, when revenue increased 18.0% from the prior-year period. The Semiconductor & Advanced Manufacturing business generated 367.4 million euros, up 16.7%, supported by stronger lithography and inspection demand.
Profitability Reaches New High
Group EBITDA increased 35.2% to 178.2 million euros from 131.8 million euros a year earlier. The EBITDA margin expanded to 22.2% from 17.5%, helped by revenue growth, a favorable product mix, particularly in the third quarter, and cost-cutting measures introduced in 2025.
Net income after tax rose about 57% to 74.0 million euros, while earnings per share increased to 1.28 euros from 0.80 euros. The performance gives investors evidence that the earlier margin improvement was reflected in reported results rather than only in preliminary figures.
Orders Strengthen Future Visibility
Order intake increased 41.4% to 1,099.2 million euros, compared with 777.3 million euros in the prior-year period. Semiconductor & Advanced Manufacturing order intake rose about 90%, while Biophotonics order intake grew about 11%. Jenoptik's book-to-bill ratio reached 1.37, up from 1.03, and the order backlog rose to 903.2 million euros from 590.8 million euros at the end of 2025.
The strong order momentum is important for the medium-term outlook, although the business mix remains uneven. Biophotonics revenue fell 1.1% to 180.1 million euros and Metrology & Production Solutions declined to 130.9 million euros amid continued weakness in automotive markets. Smart Mobility Solutions grew 11.8% to 105.6 million euros.
Guidance Focuses On Margin
Jenoptik continues to expect 2026 revenue growth of 5% to 9% from the 2025 base of 1,046.0 million euros. The Executive Board now expects an EBITDA margin of around 22% for the full year, compared with its previous range of 20% to 21% and 18.4% in 2025. Capital expenditure is expected to remain significantly below the prior-year level of 77.4 million euros, while plans to expand optical production capacity in Jena remain unchanged.
Management also pointed to the high order backlog as a basis for confidence in 2027. CEO Dr. Dominic Dorfner said the company was concentrating on delivery capabilities and capacity expansion, while CFO Dr. Prisca Havranek-Kosicek cited the backlog in her outlook for the next year.
Jenoptik stock traded at 36.05 euros on Lang & Schwarz at 11:37 CET on Tuesday, November 10, 3.35% below the Xetra close of Monday, November 9. The comparison places the current indication below the previous completed Xetra session without attributing the move to the results.
Jenoptik AG at a glance
- Company: Jenoptik AG
- ISIN: DE000A2NB601
- Stock exchange: Xetra
- Latest quote: 36.05 euros on Lang & Schwarz, Tuesday, November 10, 2026, 11:37 CET
- Comparison: 3.35% below the Xetra close of Monday, November 9, 2026
- Reported period: January through September 2026
For the broader market context, see the Current market reports.
For more company coverage, see More news and analyses on Jenoptik stock.
